Clinical features, muscle biopsy scores, myositis specific antibody profiles and outcome in juvenile dermatomyositis
Authors:
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 51 (1) , 95-100
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Clinical Characteristics of Children With Juvenile Dermatomyositis: The Childhood Arthritis and Rheumatology Research Alliance RegistryArthritis Care & Research, 2013
- The PRINTO criteria for clinically inactive disease in juvenile dermatomyositisAnnals of the Rheumatic Diseases, 2013
- Inflammatory Myopathies With Anti-Ku AntibodiesMedicine, 2012
- Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patientsArthritis Care & Research, 2009
- Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onsetRheumatology, 2009
- Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosisArthritis & Rheumatism, 2009
- Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expressionRheumatology, 2009
- International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: A tool for potential use in clinical trialsArthritis Care & Research, 2007
- The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yrRheumatology, 2006
- International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathiesArthritis & Rheumatism, 2005